Adienne
Skip to content
  • Home Page
  • Manufacturing
    • Biological
    • Cytotoxic in ready to use system delivery
      • System Delivery
        • Multichamber Flexible Bag
        • FillChoice
  • Our Products
    • Phelinun
    • Tepadina ®
      • Canadian Product Monograph
  • R&D
    • Our Pipelines
    • Research Areas
  • Contact Us
    • Locations
    • For Medical Inquiries
    • To Notify Side Effects
  • Careers

ADIENNE Pharma & Biotech announces FDA Approval of TEPADINA

Posted on 25 February 2019 by admin

This entry was posted in PressRelease. Bookmark the permalink.

Post navigation

← ADIENNE Pharma & Biotech Receives FDA’s Drug Shortage Assistance Award
ADIENNE Pharma & Biotech annuncia l’approvazione di TEPADINA da parte di FDA →
Cookie Policy
Privacy Policy
Zelle Lite Developed by ThemeIsle

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Adienne
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.